Encompass Health (NYSE:EHC) Releases FY 2024 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 3.770-4.060 for the period, compared to the consensus earnings per share estimate of 3.970. The company issued revenue guidance of $5.2 billion-$5.3 billion, compared to the consensus revenue estimate of $5.3 billion.

Encompass Health Stock Up 1.2 %

EHC opened at $77.69 on Thursday. The stock has a market capitalization of $7.78 billion, a price-to-earnings ratio of 22.39, a PEG ratio of 1.42 and a beta of 0.93. Encompass Health has a twelve month low of $52.32 and a twelve month high of $78.11. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The firm has a 50 day moving average price of $74.10 and a 200-day moving average price of $68.80.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.12. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. Equities research analysts forecast that Encompass Health will post 3.96 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Monday, April 1st will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Thursday, March 28th. Encompass Health’s dividend payout ratio is presently 17.29%.

Analysts Set New Price Targets

A number of brokerages recently commented on EHC. Truist Financial raised their target price on Encompass Health from $82.00 to $86.00 and gave the stock a buy rating in a report on Friday, February 9th. Mizuho boosted their price objective on Encompass Health from $77.00 to $82.00 and gave the company a buy rating in a research note on Friday, February 9th. Royal Bank of Canada reissued an outperform rating and issued a $83.00 target price on shares of Encompass Health in a report on Friday, February 9th. Stephens reaffirmed an overweight rating and set a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Finally, Barclays started coverage on shares of Encompass Health in a research note on Wednesday, March 6th. They issued an overweight rating and a $95.00 price objective for the company. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health has a consensus rating of Buy and an average price target of $82.56.

Hedge Funds Weigh In On Encompass Health

Several hedge funds have recently modified their holdings of EHC. Mariner LLC purchased a new position in Encompass Health during the 3rd quarter valued at approximately $244,000. GSA Capital Partners LLP bought a new position in Encompass Health during the fourth quarter valued at $203,000. State of Wyoming bought a new stake in shares of Encompass Health in the 2nd quarter worth about $200,000. Canada Pension Plan Investment Board purchased a new stake in shares of Encompass Health during the 1st quarter valued at about $178,000. Finally, Advisory Services Network LLC bought a new stake in shares of Encompass Health in the 4th quarter valued at approximately $126,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.